In May, the modern vaccine applied for full approval to the FDA, presenting the results of the 6-month trial that showed an efficacy of 90% against the virus. pfizer also announced that it was seeking final approval with 91% efficacy and Cuban vaccines rolling_on_the_floor_laughingrolling_on_the_floor_laughingrolling_on_the_floor_laughingrolling_on_the_floor_laughingrolling_on_the_floor_laughing